Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Xilio Therapeutics Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a 606.03% increase from the last price of 0.779.
High | 670.2% | 6.00 |
Med | 606.0% | 5.50 |
Low | 541.8% | 5.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 09, 2024.
Average growth rate | +18.09% |
Average growth rate | +44.92% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼